NovoCure Limited header image

NovoCure Limited

NVCR

Equity

ISIN JE00BYSS4X48 / Valor 29570025

NASDAQ (2026-08-05)

USD 16.05-1.35%

NovoCure Limited
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

NovoCure Limited, founded in 2000 by Prof. Yoram Palti, is an international oncology company specializing in providing patients with a new cancer treatment known as Tumor Treating Fields. This innovative therapy is based on the discovery of the effects of TTFields on cancer cells, which disrupt cancer cell division when applied at specific frequencies. NovoCure's mission is to offer a completely different approach to cancer therapy, offering hope to patients seeking alternative treatment options.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

40.4%1Y

-43.8%3Y

-89.8%5Y

Performance

77.0%1Y

79.2%3Y

80.2%5Y

Volatility

1869 M

Market cap (USD)

1,234,123

Daily traded volume (Shares)

30.63 / 29.83

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

0.00

0 votes

Performance:

0.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

EQUITIES OF THE SAME SECTOR

EssilorLuxottica SA

EssilorLuxottica SA Valor: 497537

Annual Return

-50%0%+50%

Risk level

110

0.56%EUR 171.45

Bausch Health Companies Inc

Bausch Health Companies Inc Valor: 42260834

Annual Return

-50%0%+50%

Risk level

110

-2.71%USD 6.28

Cassava Sciences Inc

Cassava Sciences Inc Valor: 46983284

Annual Return

-50%0%+50%

Risk level

110

-3.67%USD 0.96

Ligand Pharmaceuticals Inc

Ligand Pharmaceuticals Inc Valor: 12015449

Annual Return

-50%0%+50%

Risk level

110

0.59%USD 302.57

RadNet Inc

RadNet Inc Valor: 2812237

Annual Return

-50%0%+50%

Risk level

110

-3.12%USD 67.06

Allogene Therapeutics Inc

Allogene Therapeutics Inc Valor: 43756548

Annual Return

-50%0%+50%

Risk level

110

2.63%USD 1.95

Healthcare Services Group Inc

Healthcare Services Group Inc Valor: 938239

Annual Return

-50%0%+50%

Risk level

110

-1.34%USD 22.84

Janux Therapeutics Inc

Janux Therapeutics Inc Valor: 111742522

Annual Return

-50%0%+50%

Risk level

110

0.25%USD 16.00

Hikma Pharmaceuticals PLC

Hikma Pharmaceuticals PLC Valor: 2324471

Annual Return

-50%0%+50%

Risk level

110

-0.63%GBP 15.71

Cencora Inc

Cencora Inc Valor: 1212868

Annual Return

-50%0%+50%

Risk level

110

3.57%USD 317.22

SIX

FactSet

Clearbit

Logos provided by Clearbit